Joseph F. Gordon
2018
Compensation breakdown
Non-Equity Incentive Plan | $726,000 |
---|---|
Option Awards | $239,972 |
Salary | $501,731 |
Stock Awards | $482,117 |
Other | $12,375 |
Total | $1,962,195 |
Gordon received $726K in non-equity incentive plan, accounting for 37% of the total pay in 2018.
Gordon also received $240K in option awards, $501.7K in salary, $482.1K in stock awards and $12.4K in other compensation.
Rankings
In 2018, Joseph F. Gordon's compensation ranked 5,854th out of 14,244 executives tracked by ExecPay. In other words, Gordon earned more than 58.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,854 out of 14,244 | 59th |
Division Manufacturing | 2,219 out of 5,765 | 62nd |
Major group Chemicals And Allied Products | 826 out of 2,128 | 61st |
Industry group Drugs | 690 out of 1,817 | 62nd |
Industry Pharmaceutical Preparations | 536 out of 1,391 | 62nd |
Pay ratio
Joseph F. Gordon's Pay | $1,962,195 |
---|---|
Median Employee's Pay | $37,872 |
Pay Ratio | 52to 1 |
In 2018, the annual total compensation of Joseph F. Gordon was $1,962,195.
The annual total compensation of the median employee at Valeant Pharmaceuticals International was $37,872.
The ratio of Joseph F. Gordon's pay to the pay of median employee was therefore 52 to one.
Gordon's colleagues
We found four more compensation records of executives who worked with Joseph F. Gordon at Valeant Pharmaceuticals International in 2018.
2018
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
2018
Paul Herendeen
Valeant Pharmaceuticals International
Chief Financial Officer
2018
Thomas Appio
Valeant Pharmaceuticals International
President & Co, Head, Bausch + Lomb/International
2018
Christina Ackermann
Valeant Pharmaceuticals International